Original ResearchPublished 6 May 2026Real-world effectiveness and safety of tildrakizumab in Japanese patients with psoriasis: a single-center 52-week observational studyDaisuke Watabe · Kanako Tsunoda · Akemi Hamabata · Maki Goto · Wakako Yoshioka · Hiroo AmanoJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2026.16442
Original ResearchPublished 23 February 2026The epidemiological and clinical association between primary focal hyperhidrosis and various skin disease in Japanese patients: outpatient questionnaire analysisKeiji Kosaka · Akihiko Uchiyama · Mai Ishikawa · Sei-Ichiro MotegiJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2026.15800
